INTERNATIONAL PATENT: VERALOX THERAPEUTICS INC. FILES APPLICATION FOR "METHODS FOR TREATING HEPARIN-INDUCED THROMBOCYTOPENIA"

GENEVA, Oct. 6 -- VERALOX THERAPEUTICS INC. (321 Ballenger Center DriveSuite 125Frederick, Maryland 21703) filed a patent application (PCT/US2025/021760) for "METHODS FOR TREATING HEPARIN-INDUCED THROMBOCYTOPENIA" on Mar 27, 2025. With publication no. WO/2025/207887, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MALONEY, David J. (c/o Veralox Therapeutics321 Ballenger Center Drive, Suite 125Frederick, Maryland 21703), FLANNER, Henry H. (c/o Veralox Therapeutics321 Ballenger Center Drive, Suite 125Frederick, Maryland 217...